Skip to main content
# العنوان سنة البحث
331 Enhanced delivery of baclofen through blood brain barrier using poly (butyl cyanoacrylate) nanoparticles coated with polysorbate-80. 2009
332 Enhanced Delivery of Baclofen Through Blood-Brain Barrier Using Poly(butyl cyanoacrylate) Nanoparticles Coated with Polysorbate-80 as a Carrying Vector. 2009
333 The influence of experimental schistosomiasis on the pharmacokinetics and pharmacodynamics of phenobarbital and diphenylhydantoin in mice 2009
334 Synthesis and docking study of some pyrazolo [3,4-d]pyrimidin- 4(5h)-one derivatives as phosphodiesterase-5 inhibitors. 2009
335 The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: Relationship to blood carnitine status. 2009
336 Enhanced delivery of baclofen through blood brain barrier using poly (butyl cyanoacrylate) nanoparticles coated with polysorbate-80. 2009
337 Enhanced Delivery of Baclofen Through Blood-Brain Barrier Using Poly(butyl cyanoacrylate) Nanoparticles Coated with Polysorbate-80 as a Carrying Vector. 2009
338 Enhancement of the anti‐inflammatory and anti‐arthritic effects of theophylline by a low dose of a nitric oxide donor or non‐specific nitric oxide synthase inhibitor 2009
339 Angiotensin-converting enzyme inhibitor and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity. Pharmacological 2009
340 Protective Effect of Aminoguanidine Against Cyclosporine induced Nephrotoxicity and Hepatotoxicity in Rats: Histological and Biochemical Study. 2009